STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Initial Public Offering	At the Market Offering	Common Stock	Common Stock At the Market Offering	Additional Paid-In Capital	Additional Paid-In Capital At the Market Offering	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Beginning balances at Dec. 31, 2022	$ 95,372					$ 185,469		$ (374)	$ (89,723)
Beginning balances, shares at Dec. 31, 2022				19,402,658
Issuance of common stock, net of commissions and offering costs	65,479		$ 19,050			65,479	$ 19,050
Issuance of common stock, net of commissions and offering costs, shares				7,777,778	2,502,000
Issuance of common stock under the ESPP	366					366
Issuance of common stock under the ESPP, Shares				44,009
Issuance of common stock upon exercise of stock options	99					99
Issuance of common stock upon exercise of stock options shares				15,000
Vesting of early exercised stock options	6					6
Stock-based compensation	8,412					8,412
Unrealized gain (loss) on available-for-sale investments	649							649
Net loss	(64,732)	$ (64,700)							(64,732)
Ending balances at Dec. 31, 2023	124,701					278,881		275	(154,455)
Ending balances, shares at Dec. 31, 2023				29,741,445
Issuance of common stock under the ESPP	147					147
Issuance of common stock under the ESPP, Shares				70,700
Issuance of common stock upon exercise of stock options	$ 225					225
Issuance of common stock upon exercise of stock options shares	28,930			28,930
Vesting of early exercised stock options	$ 3					3
Issuance of common stock upon release of restricted stock units, shares				38,556
Issuance of common stock upon release of restricted stock awards ,shares				40,003
Stock-based compensation	8,338					8,338
Unrealized gain (loss) on available-for-sale investments	(244)							(244)
Net loss	(51,321)	$ (51,300)							(51,321)
Ending balances at Dec. 31, 2024	$ 81,849					$ 287,594		$ 31	$ (205,776)
Ending balances, shares at Dec. 31, 2024				29,919,634